改善骨质疏松症诊疗的干预措施:系统综述与荟萃分析
该系统综述与荟萃分析检索2003至2018年文献,纳入32项定性分析、29项定量分析研究,按健康系统、医护人员、患者三类干预评估其对骨密度测量处方和骨质疏松治疗处方的影响。结果显示结构干预对两项结局均有显著改善,患者层面干预亦有效,医护人员干预仅对治疗处方有显著作用。总体干预对骨密度测量处方影响显著,对治疗处方影响较有限。
要点
- 结构干预显著提高骨密度测量处方(OR=9.99)和治疗处方(OR=3.82)。
- 患者层面干预显著改善骨密度测量处方(OR=2.16)和治疗处方(OR=1.70)。
- 医护人员干预对骨密度测量处方无统计学显著影响(OR=2.19,95%CI 0.84-5.73)。
核心结论
- 改善骨质疏松症管理的干预措施对骨密度测量处方有显著正向影响,但对治疗处方的影响较为有限。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed/MEDLINE、Science Direct、Web of Science、Cochrane和Wiley Online Library数据库2003至2018年发表的文献。
- 共筛选4268条记录,32项研究纳入定性分析,29项研究纳入定量分析,干预按健康系统(结构干预)、医护人员和患者三类划分。
主要发现
- 结构干预显著改善骨密度测量处方(OR=9.99,95%CI 2.05-48.59)和治疗处方(OR=3.82,95%CI 2.16-6.75)。
- 医护人员干预对骨密度测量处方的影响未达统计学显著性(OR=2.19,95%CI 0.84-5.73),但显著改善治疗处方(OR=3.82,95%CI 2.16-6.75)。
- 患者层面干预显著改善骨密度测量处方(OR=2.16,95%CI 1.62-2.89)和治疗处方(OR=1.70,95%CI 1.35-2.14)。
临床怎么用
- 可优先考虑结构干预以同时提升骨密度测量和治疗处方,患者层面干预可作为辅助手段。
- 医护人员干预对治疗处方有效,但对骨密度测量处方作用不明确,需结合其他策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteoporosis (OP) is a major public health concern, but still OP care does not meet guidelines. Interventions have been developed to improve appropriate OP management. The objective of the present study was to systematically review the current literature to ascertain the efficacy of interventions to improve OP care and characterize interventions taking into account elements related to their potential cost and feasibility. Studies published from 2003 to 2018 were retrieved from PubMed/MEDLINE, Science Direct, Web of Science, Cochrane, and Wiley Online Library databases. Screening of references and quality assessment were independently performed by two reviewers. We classified interventions into three types according to the target of the intervention: health system (structural interventions), healthcare professional (HCP), and patient. Meta-analysis was performed by type of intervention and their effect on two outcomes: prescription of BMD measurement and prescription of OP therapy. A total of 4268 records were screened; 32 studies were included in the qualitative analysis and 29 studies in the quantitative analysis. Structural interventions strongly and significantly improved prescription of BMD measurement (OR = 9.99, 95% CI 2.05; 48.59) and treatment prescription (OR = 3.82, 95% CI 2.16; 6.75). The impact of HCP-centered interventions on BMD measurement prescription did not reach statistical significance (OR = 2.19, 95% CI 0.84; 5.73) but significantly improved treatment prescription (OR = 3.82, 95% CI 2.16; 6.75). Interventions involving patients significantly improved the prescription of BMD measurement (OR = 2.16, 95% CI 1.62; 2.89) and treatment prescription (OR = 1.70, 95% CI 1.35; 2.14). Interventions to improve OP management had a significant positive impact on prescription of BMD measurement but a more limited impact on treatment prescription.
引用
- Martin J, Viprey M, Castagne B, et al. Interventions to improve osteoporosis care: a systematic review and meta-analysis. Osteoporos Int. 2020. PMID: 31993718. doi:10.1007/s00198-020-05308-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。